These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27404023)

  • 1. Insulin-Mediated Downregulation of Apolipoprotein A-I Gene in Human Hepatoma Cell Line HepG2: The Role of Interaction Between FOXO1 and LXRβ Transcription Factors.
    Shavva VS; Bogomolova AM; Nikitin AA; Dizhe EB; Tanyanskiy DA; Efremov AM; Oleinikova GN; Perevozchikov AP; Orlov SV
    J Cell Biochem; 2017 Feb; 118(2):382-396. PubMed ID: 27404023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells.
    Shavva VS; Bogomolova AM; Nikitin AA; Dizhe EB; Oleinikova GN; Lapikov IA; Tanyanskiy DA; Perevozchikov AP; Orlov SV
    Cell Stress Chaperones; 2017 Jan; 22(1):123-134. PubMed ID: 27896567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner.
    Shavva VS; Babina AV; Nekrasova EV; Lisunov AV; Dizhe EB; Oleinikova GN; Orlov SV
    Cell Biochem Biophys; 2023 Mar; 81(1):151-160. PubMed ID: 36251137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells.
    Shavva VS; Mogilenko DA; Bogomolova AM; Nikitin AA; Dizhe EB; Efremov AM; Oleinikova GN; Perevozchikov AP; Orlov SV
    J Cell Biochem; 2016 Sep; 117(9):2010-22. PubMed ID: 26813964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and functional interactions between nuclear receptor LXRα and the forkhead box transcription factor FOXA2 regulate the response of the human lipoprotein lipase gene to oxysterols in hepatic cells.
    Kanaki M; Tiniakou I; Thymiakou E; Kardassis D
    Biochim Biophys Acta Gene Regul Mech; 2017 Aug; 1860(8):848-860. PubMed ID: 28576574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
    Mogilenko DA; Dizhe EB; Shavva VS; Lapikov IA; Orlov SV; Perevozchikov AP
    Biochemistry; 2009 Dec; 48(50):11950-60. PubMed ID: 19883121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism.
    Xiong T; Li Z; Huang X; Lu K; Xie W; Zhou Z; Tu J
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G598-G607. PubMed ID: 30817182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs.
    Shavva VS; Mogilenko DA; Nekrasova EV; Trulioff AS; Kudriavtsev IV; Larionova EE; Babina AV; Dizhe EB; Missyul BV; Orlov SV
    Mol Cell Biochem; 2018 Nov; 448(1-2):211-223. PubMed ID: 29442267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
    Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
    Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
    Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
    Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
    J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.
    Chi HC; Chen SL; Cheng YH; Lin TK; Tsai CY; Tsai MM; Lin YH; Huang YH; Lin KH
    Cell Death Dis; 2016 Aug; 7(8):e2324. PubMed ID: 27490929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
    Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
    Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL.
    Kurano M; Iso-O N; Hara M; Ishizaka N; Moriya K; Koike K; Tsukamoto K
    Lipids Health Dis; 2011 Aug; 10():134. PubMed ID: 21819577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of nutrients and nutritional mediators in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression.
    Rescigno T; Capasso A; Tecce MF
    J Cell Physiol; 2018 Apr; 233(4):3306-3314. PubMed ID: 28888048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
    Dong Y; Gao G; Fan H; Li S; Li X; Liu W
    PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Role of Liver X Receptor (LXR)
    Hansmann E; Mennillo E; Yoda E; Verreault M; Barbier O; Chen S; Tukey RH
    Drug Metab Dispos; 2020 Apr; 48(4):255-263. PubMed ID: 31980500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Promotes 2-Deoxy-2-[
    Wang Z; Kang F; Gao Y; Liu Y; Xu X; Ma X; Ma W; Yang W; Wang J
    Mol Imaging Biol; 2018 Jun; 20(3):388-397. PubMed ID: 29256045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.